1. Leveraging digital health and care coordination to improve health services delivery to vulnerable populations. We embrace big data and technology to design, develop, and deliver economic and effective services for patients in the area of cancer screening and follow-up.
2. Development of intestinal organoids from humans to understand barrier function, systemic inflammation, inflammatory bowel disease, HIV persistence, infection, and microbiome. Approaches employed: organoid models, isolation of epithelial cells, lymphocytes, microbiota, and interventional trials such as fecal transplant.
March 15, 2021 - February 28, 2026 - Cytomegalovirus (CMV), the gut barrier and immune dysfunction in HIV , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01AI155680
August 12, 2020 - July 31, 2025 - In Vivo PET Imaging of HIV Infection , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01AI152932
January 10, 2020 - December 31, 2024 - Modeling intestinal dysfunction in HIV infection with organoid technology , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DK123746
August 16, 2019 - July 31, 2024 - Understanding the Multilevel Drivers of Liver Cancer Disparities , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01CA225478
Pomona College, Claremont, CA, BA, 1993-1997, Chemistry
Harvard Medical School, Boston, MA, MD, 1997-2002, Medicine
Harbor-UCLA Medical Center, Torrance, CA, Residency, 2002-2005, Internal Medicine
University of California, San Francisco, CA, Fellowship, 2005-2008, Gastroenterology
University of California, San Francisco, CA, MAS, 2006-2008, Epidemiology and Biostatistics